Friday 27th May 2011 |
Text too small? |
Pharmacybrands is electing to pay down debt rather than pay shareholders a dividend from a year in which it increased profit.
The company made a $5.16 million profit in the 12 months to March 31, up from $3.5 million last year when it only owned Life Pharmacy for part of the year. The profit was achieved on revenue of $21.7 million from $16.2 million last year.
"The result shows that the company has successfully integrated the two businesses it brought together in the previous year," said chairman Peter Merton.
The company's partnership model, with a 49% investment by the company alongside a 51% holding by a pharmacist partner working in the business, continues to be a profitable investment model for all parties.
Pharmacybrands had cash reserves in excess of $15 million as March 31 but it has made two acquisitions since then.
"The board therefore believes that it is more prudent to reduce this debt rather than pay out a dividend at this time," the company said.
No comments yet
2025 Annual Shareholders' Meeting and Director Nominations
Meridian Energy monthly operating report for July 2025
August 15th Morning Report
VGL upgrades aspirations, accelerates to meet client demand
August 14th Morning Report
VHP - Focus on Fundamentals: Driving Operational Performance
August 13th Morning Report
Devon Funds Morning Note - 12 August 2025
Spark announces sale of 75% of data centre business
Blackpearl Announces $15M Capital Raise & Market Update